Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

University of Vermont

Status: Unknown

Conditions: Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT01148407

VCC 0806

Details and patient eligibility

About

Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with a diagnosis of malignancy

Exclusion criteria

• Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy